
Bio Green Med Solution
(NASDAQ) CYCC
Bio Green Med Solution Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$1.53M
Net Income (TTM)
-$3.11M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Estimated Earnings Date
Aug 12, 2025
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Estimated Earnings Date
Aug 12, 2025
CYCC News
Cyclacel Announces New Stock Issue
5 of Last Week's Biggest Losers
4 Biotechs' Dominant Moves
ASCO Pops and Drops
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bio Green Med Solution
Industry
Biotechnology
Sector
Health CareCEO
Sing Ee Wong, DBA
Website
www.cyclacel.comHeadquarters
Berkeley Heights, NJ 07922, US
CYCC Financials
Key Financial Metrics (TTM)
Gross Margin
18.36%
Operating Margin
-238.49%
Net Income Margin
-204.20%
Return on Equity
-51.20%
Return on Capital
-123.17%
Return on Assets
-41.17%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
-2.60%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$279.00K
Operating Income
-$3.64M
EBITDA
-$1.55M
Operating Cash Flow
-$5.04M
Capital Expenditure
-$1.00K
Free Cash Flow
-$5.05M
Cash & ST Invst.
$3.34M
Total Debt
$0.00
Bio Green Med Solution Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$778.00K
N/A
Gross Profit
$142.00K
N/A
Gross Margin
18.25%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
12
N/A
Net Income
-$197.00K
-143.2%
EBITDA
-$245.00K
+95.1%
Quarterly Fundamentals
Total Cash
$3.34M
-3.2%
Total Debt
$0.00
-100.0%
Accounts Receivable
$1.19M
N/A
Inventory
$947.00K
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
N/A
Return on Assets
-41.17%
N/A
Return on Invested Capital
-53.74%
N/A
Free Cash Flow
-$279.00K
-8492.5%
Operating Cash Flow
-$278.00K
-8461.7%